The renewal that nobody remembered.

Marketing authorization in Brazil expired. Nobody noticed until a distributor couldn't import. The renewal application should have been filed six months earlier. Now there's a gap. Product can't be sold, patients can't get medicine, and re-registration will take eighteen months. One spreadsheet. One missed update. One country out of sixty-three where the product is registered. The cost: $4 million in lost revenue and a regulatory relationship that will take years to rebuild.

This is what happens when regulatory lifecycle management depends on someone remembering. Registrations aren't one-time events. Renewals, periodic reports, commitment fulfillments, license maintenance fees. Each market has requirements that recur on different schedules. Nobody can track sixty-three markets in a spreadsheet without something slipping through.

How many markets is Product X registered in? When does the Thailand registration expire? What variations are pending in the EU? Which markets still need the latest labeling update? Seal maintains your complete registration portfolio. Every product, every market, every status. So these answers are immediate rather than requiring spreadsheet archaeology or checking with local affiliates.

The lifecycle tracks automatically. Five-year renewal coming up in Mexico? Task created eighteen months out. Annual report due in Japan? Reminder generated. Pharmacovigilance agreement expiring? Flag raised. The system knows what's coming and nobody needs to remember.

When operational changes happen, regulatory impact maps automatically. A manufacturing process changes. Which markets require notification? Which require prior approval? When change control approves the change, affected registrations identify themselves, regulatory affairs sees what submissions are needed, and tracking continues through completion.

Product labeling varies by market: different languages, different required statements, different formats. When core labeling changes, Seal identifies which market-specific labels need updating and tracks artwork versions linked to the registrations they support. The EU requires one set of statements, Brazil requires another, and the system knows which is which.

The registration dossier is the master regulatory file. Module 1 varies by region while Modules 2-5 are ICH common. As the product evolves, the dossier evolves. Current approved content, pending variations, historical versions. When you need to know what you submitted in the original NDA, the answer is there rather than in an archive box someone has to locate.

Agency correspondence accumulates over years. Regulators ask questions, you respond, they follow up. Seal maintains every question and response indexed by product and market. When preparing a new submission, see what you've previously told this agency about this topic. Consistency matters. Regulators notice when your story changes.

Approval often comes with strings attached. Post-marketing commitments, risk evaluation and mitigation strategies, pediatric study requirements, post-authorization safety studies. Miss a commitment deadline and you've created a compliance issue with the agency that approved your product.

Seal tracks commitments from the moment they're imposed. Milestone dates, deliverables, responsible parties. All visible. As deadlines approach, tasks generate. When commitments complete, evidence links to the record. The FDA asks about your REMS milestones? The status is current, not reconstructed from email threads.

You add a manufacturing site. Sixty-three markets need to know. But each has different requirements. The US wants a CBE-30 supplement. The EU needs a Type II variation. Japan accepts notification. Brazil requires prior approval. Canada wants a Level II change. And so on, sixty-three times.

Without a system, you're managing sixty-three spreadsheets, hoping someone remembers Korea's requirements differ from Taiwan's.

Seal maps the change to market-specific requirements automatically. Define the global change once. The system identifies every affected registration, determines what each market requires, generates the submission tasks, and tracks progress. Regional teams see what's coming from global. Global sees what's completing locally. Nothing slips through because nothing depends on someone remembering.

Regulations change constantly. New guidance, evolving requirements, enforcement trends. A new stability requirement in Japan flags for products registered there. EU pediatric requirements changing link to affected products. You see what's changing and assess impact proactively rather than discovering it when someone asks why you're not compliant.

In many markets, a local entity holds the registration. Marketing authorization holders, local agents, distributors with regulatory obligations. Seal tracks who holds what, where, with agreement terms and renewal dates. When an agent agreement expires, you know before the registration lapses.

Site registrations matter too. Manufacturing sites need authorization in many markets. When you add a new manufacturing site, Seal identifies which registrations need updating. When a CMO relationship ends, you know which registrations are affected before supply chain disruption.

Global product, local product name, dosage form, strength, presentation, pack, shelf life, storage, indication, population, route, manufacturing and testing sites, specifications, labeling, and legal status form the approved market state.

Seal preserves the effective state for every date. Teams can compare the global source, submitted proposal, authority questions, and final approval without flattening them into one mutable record.

Authority, country or region, procedure, product class, application type, variation category, lead time, sequence, language, fee, forms, electronic standard, signature, validation rule, review clock, and effective-date constraint define a regulatory requirement.

Rules are versioned and never silently recalculate an already approved strategy. When a rule changes, affected open and future work is identified for assessment.

A proposed launch or change receives a market-by-market strategy with classification, rationale, precedent, consultation, required data, submission grouping, dependency, target filing, approval-before-implementation rule, risk, and owner.

Alternatives and uncertainty remain visible. The approved strategy becomes the source for plans, not an undocumented conclusion in a slide deck.

Application, sequence, lifecycle operation, dossier section, content plan, document, source record, validation result, dispatch, acknowledgement, fee, milestone, review clock, question, response, approval, and implementation remain connected.

The RIMS record governs what must be filed and what it changes. Publishing technology may create an eCTD package, but does not replace the product, registration, requirement, and commitment model.

Information requests, deficiency letters, meeting questions, commitments, responses, supporting analyses, internal positions, due dates, extensions, submissions, and outcomes retain topic and product context.

Future teams can find what the company told an authority about a process, specification, method, safety signal, or labeling rationale—and whether that statement still constrains the product.

Post-approval studies, stability pulls, validation, protocol submissions, annual reports, safety measures, labeling updates, inspections, and other conditions each retain authority, legal basis, milestone, deliverable, dependency, owner, evidence, status, and closure acceptance.

Completion requires the promised evidence and, where relevant, authority acceptance. A submitted deliverable is not automatically a fulfilled commitment.

Products, substances, organizations, sites, dosage forms, strengths, routes, indications, territories, procedures, statuses, and authority identifiers use governed terms and mappings.

Local values remain available for exact reporting while canonical terms support global search, aggregation, and exchange.

Mandatory attributes, cross-field checks, duplicate detection, controlled-value checks, date logic, orphaned relationships, expired contacts, and stale registration status create owned data-quality issues.

Steward queues, severity, due date, correction evidence, approval, and recurring-rule metrics make quality measurable rather than an annual cleanup.

Portfolio transfers preserve source-system identifiers, record owners, migration lineage, validation, gaps, legal transfers, authority notifications, marketing-authorization-holder changes, dossiers, commitments, correspondence, and effective dates.

Records can change custody without losing who asserted what, when, or from which evidence.

Statutory due dates, internal targets, forecast filing, authority clock stops, response dates, approval forecasts, renewal windows, implementation deadlines, and commitment milestones remain distinct.

Dependencies and scenario dates expose the consequence of a late prerequisite without rewriting the legal deadline.

Teams can query registrations at risk of lapse, markets awaiting a safety update, changes blocked on prior approval, commitments due by quarter, products using a specific site, dossiers affected by a source-document revision, and authority questions on a recurring topic.

Every aggregate drills to the dated registration, requirement, submission, or obligation that produced it.

Global regulatory operations governs core data and standards. Product and regional owners govern strategy and local truth. CMC, labeling, safety, clinical, quality, and supply contributors own their evidence. Approvers remain accountable for the regulatory position.

Role and attribute-based access supports affiliates and partners without fragmenting the master portfolio.

For a product and market, Seal can reconstruct the approval basis, current registered detail, submitted and approved changes, correspondence, open commitments, renewals, sites, labels, owners, and data-quality status.

That chronology is useful not only for inspection, but for licensing, acquisition, divestiture, supply decisions, and product retirement.